Koers Compass Biotechnologies, Inc. Other OTC
Aandelen
US20452Q1031
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 158K 147K |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 | Nettowinst (verlies) 2019 | - 0 | EV/omzet 2018 | - |
Nettoschuld 2018 | 516K 480K | Nettoschuld 2019 | 480K 447K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-2,59
x | K/w-verhouding 2019 |
-3,95
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Mathew Knowles
SAM | Sales & Marketing | - | 22-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,50% | 6,2 mld. | |
-22,89% | 4,1 mld. | |
+9,36% | 3,41 mld. | |
-19,39% | 2,83 mld. | |
-11,05% | 2,29 mld. | |
+45,24% | 1,93 mld. | |
-7,51% | 1,52 mld. | |
+46,81% | 1,51 mld. | |
-18,04% | 1,49 mld. |